These results clearly indicate that Nrf2 transcription in lung cancer cells is predominately down-regulated by wild-type p53 via decreased Sp1 binding to the Nrf2 promoter, but is not affected by mutant p53. The gene discussed is TP53; the disease is lung carcinoma.